Cite

    Ji Eun Park et al.. “Polymer micelle formulation of proteasome inhibitor carfilzomib as a potential strategy to improve metabolic stability and anti-cancer efficacy in human multiple myeloma and lung cancer.” Drug metabolism and pharmacokinetics, vol. 32, no. 1, n.d., pp. S46–. http://access.bl.uk/ark:/81055/vdc_100040140985.0x000024